TrialX provides cutting-edge information on new medical treatments and clinical trials in your area.
Meet Dory , your personalized virtual assistant to find clinical trials. Go head, ask her anything. x
All > North Carolina Investigators

Site Reference ID/Investigator# 25041

Site Reference ID/Investigator# 25041


Chapel Hill, North Carolina - 27599-7570
  • CLINICAL TRIALS 1
  • CONDITIONS1
  • INTERVENTIONS3
  • SINCE2010
A Trial of ABT-888 in Combination With Temozolomide Versus Pegylated Liposomal Doxorubicin Alone in Ovarian Cancer

February 2010 - March 2012
Ovarian Neoplasms

Temozolomide

Abt-888

Pegylated Liposomal Doxorubicin

Related Investigators

Michael Morse, MD

Duke Cancer Research Institute, Duke University Duke University Medical Center Duke Comprehensive Cancer Center

Marybeth Whitney, BSN, CC

Carolinas Healthcare System/Carolinas Rehabilitation

Vu Nguyen, MD

Carolinas Healthcare System/Carolinas Rehabilitation

James N. Atkins, MD

Wayne Memorial Hospital, Incorporated Southeastern Medical Oncology Center - Goldsboro Southeastern Medical Oncology Center

Timothy J. Finnegan

Alamance Cancer Center at Alamance Regional Medical Center

Janak K. Choksi, MD

Alamance Cancer Center at Alamance Regional Medical Center Alamance Regional Medical Center Cancer Center

Sandeep R. Pandit

Alamance Cancer Center at Alamance Regional Medical Center Alamance Regional Medical Center

Jane K. Ybanez

Alamance Cancer Center at Alamance Regional Medical Center

James E. Radford, MD

Pardee Memorial Hospital

Kristi N. Owens

Pardee Memorial Hospital

©2012 Applied Informatics, Inc.
As Seen On:
  • New York Times
  • USA Today
  • bio-itworld logo